Only Available By Prescription
Sign up to get notified if we do in the future.
We guarantee the lowest price on all of our prescription products. If you find your medications cheaper at any other recognized licensed mail order pharmacy, we will not only match their price, we will beat it by 25% of the difference. It is our 125% price match guarantee!
Example: If you find a product on Canada Drugs Direct for $50.00 and find the same product for $40.00 at another mail order pharmacy, we will provide you with a $12.50 discount, bringing your total to $37.50.
To get the discount please make sure to mention the price match to the customer service team when they call to collect payment for your order. Or call toll free at 1-888-904-8467 to place the order through the phone.
Terms & Conditions of Program
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Cagrilintide is an investigational long-acting amylin analogue developed for the treatment of obesity and overweight in individuals with or without type 2 diabetes. It mimics the physiological effects of endogenous amylin, a hormone co-secreted with insulin, to regulate appetite and food intake. Cagrilintide works by delaying gastric emptying and increasing satiety signals in the brain, leading to reduced caloric intake and body weight. It is being evaluated as a once-weekly subcutaneous injection, often in combination with GLP-1 receptor agonists such as semaglutide, to enhance weight loss outcomes.
| Fact Table | |
| Formula | C289H440N78O88S1 |
| License | Investigational |
| Bioavailability | ~85% (subcutaneous) |
| Legal status | Investigational |
| Chemical Name | Cagrilintide (AC-960) |
| Elimination half-life | 6–8 days |
| Dosage (Strength) | 0.3 mg to 4.5 mg weekly (in trials) |
| Pregnancy | Not recommended (insufficient data) |
| Brands | Not marketed yet |
| Protein binding | >99% |
| PubChem CID | 145996392 |
| MedlinePlus | Not listed |
| ChEBI | Not available |
| ATC code | None assigned |
| DrugBank | DB16495 |
| KEGG | Not listed |
| Routes of administration | Subcutaneous injection |
As an investigational agent, Cagrilintide is administered subcutaneously under the supervision of a healthcare provider in a clinical trial setting. In studies, it has been dosed once weekly, with titration to target doses based on tolerability and treatment response. Final dosage and administration schedules are subject to trial protocols or future regulatory guidance.
Active Ingredient: Cagrilintide (a modified amylin analogue) Full excipient details will be disclosed upon regulatory approval or expanded access availability.
Cagrilintide is not yet approved for general use and is currently contraindicated outside clinical research settings. Potential contraindications, based on its mechanism of action, may include:
Use is limited to controlled clinical settings. Patients should be monitored for gastrointestinal adverse effects, hypoglycemia (especially if used with insulin or insulin secretagogues), and changes in appetite or weight. The combination of Cagrilintide with other incretin-based therapies may enhance efficacy but also risk of gastrointestinal intolerance. Long-term cardiovascular and endocrine effects are under investigation.
Exceptional Customer Service
We pride ourselves on delivering excellent customer service with as much accessibility as possible.
If you have any questions at all, or would like to place an order, you are encouraged to contact us by toll-free
phone 1-888-904-8467 or email info@canadadrugsdirect.com.
Top Safety and Quality
Canada Drugs Direct employs dedicated, professional licensed pharmacists to ensure that each and every order is reviewed before it is dispensed for the safety and health of our customers. At CanadaDrugsDirect.com, your health is our top priority.
Product Reviews